Conferences
Global Corruption and Bribery Compliance for Life Sciences
Building a solid understanding of the new regulatory landscape
The Department of Justice will be vigilant in holding companies and individuals who break the law accountable – not only through civil actions, but by bringing criminal indictments.”
Lanny Breuer Assistant Attorney General for the U.S. Department of Justice, November 2009In September 2009, a pharmaceutical company paid over $1.3 billion – the largest fine every imposed in the US – for illegal activities at home and abroad. Since 2008, fines and penalties of approximately $2.8 billion were assessed against 36 companies and 64 individuals by the Securities and Exchange Commission. And in 2010, the UK passed a strict new anti-bribery act that is even more rigorous.
In the globalized world of pharmaceuticals, biotechnology and medical devices, failure to play by the rules can mean lost revenue, reputation and market share. So with IQPC launching it's inauguaral Global Corruption and Bribery Compliance for Life Sciences Conference at such a pertienent time, can your company afford not to attend?
>> Read more